John Borshoff – Managing Director – Deep Yellow (ASX:DYL) is successfully progressing a dual-pillar growth strategy to establish a globally diversified, Tier-1 uranium company to produce 10+ Mlb pa.
Copyright 2024 – Finance News Network
Source: Finance News Network
19 May 2023 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the significance of recent announcements on the back of a surge in trading volume.
Read More07 Sep 2022 - IVE Group (ASX:IGL) Executive Chairman Geoff Selig discusses full-year results, the recent acquisition of Ovato and the launch of the Lasoo e-commerce platform.
Read More14 Oct 2024 - Hiremii Limited (ASX:HMI) Managing Director and CEO Andrew Hornby discusses revolutionising recruitment through AI integration, touching on the company's revenue growth, international expansion, and opportunities in the resources and energy sectors.
Read More27 Sep 2023 - Geoff Selig, Executive Chairman of IVE Group Limited (ASX:IGL), discusses FY23 results and the acquisition of Ovato.
Read More22 Oct 2019 - QEM Limited (ASX:QEM) Executive Director & CEO, David Fitch and GM & Chief Geologist, Scott Drelincourt discuss the company’s Julia Creek vanadium and oil shale tenements in NW QLD, drill results and strategy.
Read More13 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager Kieran Kennedy discuss the FY25 full-year results of Mirrabooka Investments (ASX:MIR).
Read More13 Dec 2023 - Chilwa Minerals Limited (ASX:CHW) Managing Director Cadell Buss discusses surprising drilling results and outlines future exploration plans.
Read More29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
Read More08 Nov 2023 - Hatch Managing Director of Australia and Asia Jan Kwak discusses key commodities, geographical opportunities, innovation, applying the circular economic model to mining, and the process of producing feasibility studies.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More
